Nicotine gum is a readily available over-the-counter (OTC) product designed to aid individuals in smoking cessation. It helps those who are dependent on tobacco to reduce their cigarette consumption and ultimately quit smoking altogether. It can be used after every 2 hours to prevent withdrawal symptoms proactively. It can also be utilized to address more intense cravings, especially when combined with a nicotine patch. It falls under the category of smoking cessation aids and comes in the form of flavored chewing gum. When the gum is chewed, nicotine is released and absorbed into the bloodstream through the lining of the mouth. This process helps alleviate nicotine cravings gradually, minimize withdrawal symptoms, and decrease the urge to smoke. It is commonly available in three variants with varying nicotine content, such as 2mg, 4mg, and 6mg. Individuals can choose the suitable variant based on the number of cigarettes they typically consume daily. At present, nicotine gum is gaining immense traction across the globe due to the increasing awareness among the masses about the dangerous effects of smoking on their health.
How big is the global nicotine gum market?
The global nicotine gum market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
Nicotine Gum Market Trends:
The global nicotine gum market is primarily driven by the surging number of smokers worldwide and the increasing cases of lung cancer and other respiratory disorders. Moreover, smoking is widely recognized as a leading cause of chronic diseases, including coronary heart disease (CHD), stroke, oropharyngeal cancer, esophageal cancer, tuberculosis, rheumatoid arthritis, and various immune-related ailments. In line with this, the rising awareness about these health risks and increasing emphasis on personal well-being are positively influencing market growth. Along with this, the surging adoption of smoking cessation therapies is another major growth-inducing factor.
Additionally, several governments and non-governmental organizations (NGOs) in both developed and emerging nations are actively promoting smoking cessation products, such as nicotine gums, particularly among the youth struggling with tobacco addiction, which in turn has catalyzed the market growth. Besides this, nicotine manufacturers are introducing new and innovative smoking cessation products. including nicotine gums and patches with improved flavor and texture due to an increasing number of deaths from tobacco smoking, thereby propelling the market growth.
Furthermore, continuous product innovation, such as the development of nicotine lozenges and unique product variants, such as sugar-free nicotine gums, is contributing to the market growth. Apart from this, the rising product demand from rehab clinics and medical institutions for nicotine cessation has accelerated the product adoption rate. Other factors, including extensive research and development (R&D) activities, increasing promotion of anti-smoking campaigns, favorable government initiatives to control smoking, and rapid urbanization, are anticipated to create a positive market outlook.
Download your free sample brochure: https://www.imarcgroup.com/nicotine-gum-market/requestsample
What is included in market segmentation?
The report has segmented the market into the following categories:
Segmentation by Type:
- 2 Mg Nicotine Gum
- 4 Mg Nicotine Gum
- 6 Mg Nicotine Gum
Segmentation by Application:
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
Segmentation by Distribution Channel:
- Retail Pharmacies
- Specialty Stores
- Online Stores
- Others
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Latest Market Research Reports:
Dermatological Drugs Market: https://www.imarcgroup.com/dermatological-drugs-market
Cattle Healthcare Market: https://www.imarcgroup.com/cattle-healthcare-market
Digital X-Ray Devices Market: https://www.imarcgroup.com/digital-x-ray-devices-market
Pharmaceutical Quality Management Software Market: https://www.imarcgroup.com/pharmaceutical-quality-management-software-market
Viscosupplementation Market: https://www.imarcgroup.com/viscosupplementation-market
Biopreservation Market: https://www.imarcgroup.com/biopreservation-market
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:134 N 4th St.
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com